Skip to main content
. Author manuscript; available in PMC: 2014 May 13.
Published in final edited form as: Brain Res. 2013 Mar 19;1510:38–47. doi: 10.1016/j.brainres.2013.03.010

Figure 4.

Figure 4

Somatostatin did not influence NMDA mediated striatal NO production. (A) 3-Nitrotyrosine (3-NT) immunoreactivity was used as an indicator of striatal nitric oxide (NO) production (images taken at 63X). (B) Co-infusion of NMDA with OCT (SST analogue) had no effect on the NMDA-induced increase in 3-NT striatal levels. Mice (n=6) received an intrastriatal microinjection of a mixture of OCT and NMDA. The control group only received an infusion of aCSF. Animals were then sacrificed at 24 hours after NMDA treatment. (* p<0.05, **p<0.01 as compared to the aCSF group).